KPIs & Operating Metrics(New)
Growth Metrics

Arcosa (ACA) EBITDA Margin (2017 - 2026)

Arcosa's EBITDA Margin history spans 10 years, with the latest figure at 8.24% for Q1 2026.

  • On a quarterly basis, EBITDA Margin rose 75.0% to 8.24% in Q1 2026 year-over-year; TTM through Mar 2026 was 11.8%, a 445.0% increase, with the full-year FY2025 number at 11.86%, up 417.0% from a year prior.
  • EBITDA Margin hit 8.24% in Q1 2026 for Arcosa, down from 11.02% in the prior quarter.
  • Over the last five years, EBITDA Margin for ACA hit a ceiling of 41.6% in Q4 2022 and a floor of 5.28% in Q3 2024.
  • Historically, EBITDA Margin has averaged 11.06% across 5 years, with a median of 8.72% in 2023.
  • Biggest five-year swings in EBITDA Margin: surged 3861bps in 2022 and later crashed -3424bps in 2023.
  • Tracing ACA's EBITDA Margin over 5 years: stood at 41.6% in 2022, then tumbled by -82bps to 7.35% in 2023, then fell by -12bps to 6.48% in 2024, then surged by 70bps to 11.02% in 2025, then fell by -25bps to 8.24% in 2026.
  • Business Quant data shows EBITDA Margin for ACA at 8.24% in Q1 2026, 11.02% in Q4 2025, and 14.08% in Q3 2025.